WHO to begin pilot prequalification of biosimilars for cancer treatment

4 May 2017 | Geneva – This year WHO will launch a pilot project for prequalifying biosimilar medicines, a step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries. In September, WHO will invite manufacturers to submit applications for prequalification of biosimilar versions of two products …